![Marc Banjak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Banjak
General Counsel bei
IBIO, INC.
Vermögen: 35 000 $ am 31.07.2026
Profil
Marc A. Banjak is currently Chief Legal Officer at iBio, Inc. since 2025.
Formerly, Mr. Banjak was General Counsel at Istari Oncology, Inc., General Counsel at Dova Pharmaceuticals, Inc. from 2017 to 2021, and a Member of The Colorado Bar Association.
Education includes undergraduate studies at Franklin & Marshall College and graduate studies at Sturm College of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IBIO, INC. 0,07 % | 26.03.2026 | 25.000 ( 0,07 % ) | 35 000 $ | 31.07.2026 |
Aktive Positionen von Marc Banjak
| Unternehmen | Position | Beginn |
|---|---|---|
| IBIO, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Marc Banjak
| Unternehmen | Position | Ende |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | General Counsel | 01.04.2021 |
The Colorado Bar Association | Corporate Officer/Principal | - |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Comptroller/Controller/Auditor | - |
Ausbildung von Marc Banjak
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Colorado Bar Association | |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Sturm College of Law
 Sturm College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
